Valuation — not yet established
No valuation for RareCyte is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($130.2M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for RareCyte
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2023 | Early Stage VC | $13.2M | ▮ | ▮ |
| Aug 2021 | Early Stage VC | $24.0M | ▮ | ▮ |
| Dec 2019 | Early Stage VC | $22.2M | ▮ | ▮ |
| May 2018 | Seed Round | $5.0M | ▮ | ▮ |
| Jul 2017 | Early Stage VC | $15.4M | ▮ | ▮ |
How RareCyte's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For RareCyte, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has RareCyte raised?
- RareCyte has raised $130.2M in total funding across 5 recorded rounds.
- When did RareCyte last raise?
- RareCyte last raised in Jul 2023 (Early Stage VC), raising $13.2M.